Clear Acne Body

Description

No description information is available for the drug.

Uses and Indications

Clear Acne Body Spray is indicated for the treatment of acne.

There are no teratogenic or nonteratogenic effects associated with this product.

Dosage and Administration

After cleansing the skin with Paula's Choice Clear Pore Normalizing Cleanser and exfoliating with Paula's Choice Clear Anti-Redness Exfoliating Solution, the affected area should be treated with a thin layer of the product. This application can be performed one to three times daily, depending on the severity of the condition and as directed by a healthcare professional.

To apply, the container should be held 4 to 6 inches away from the skin. It is important to avoid spraying directly onto the face; instead, the product should be sprayed onto the hands and then gently applied to the facial area.

Initial treatment should begin with one application per day. Based on the individual's response and tolerance, the frequency may be gradually increased to two or three times daily. If the patient experiences bothersome dryness or peeling, it is advisable to reduce the application frequency to once daily or every other day.

Contraindications

There are no specific contraindications listed for this product. However, it is advised that if the product is swallowed, immediate medical assistance should be sought or the Poison Control Center should be contacted.

Warnings and Precautions

For external use only, this product should not be applied to broken skin or used on large areas of the body. Caution is advised when using this product in conjunction with other topical acne medications, as the likelihood of skin irritation and dryness may increase. If irritation occurs, it is recommended to limit the use to one topical acne medication at a time to mitigate adverse effects.

It is imperative to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

No specific laboratory tests are required for the safe use of this product; however, healthcare professionals should remain vigilant regarding the potential for skin reactions and advise patients accordingly.

Side Effects

Patients should be aware that the product is intended for external use only and should not be applied to broken skin or large areas of the body. The use of this product in conjunction with other topical acne medications may increase the likelihood of skin irritation and dryness. In the event that irritation occurs, it is advised to limit the use to one topical acne medication at a time to mitigate adverse reactions.

These precautions are essential to ensure the safety and efficacy of the treatment, as concurrent use may exacerbate skin sensitivity.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Clear Acne Body (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is recommended.

In cases where skin irritation occurs or worsens, the use of this medication should be discontinued, and a healthcare professional should be consulted.

Geriatric Use

There is no specific information regarding the use of Clear Acne Body Spray (salicylic acid) in geriatric patients. The prescribing information does not provide details on dosage adjustments, safety concerns, or special precautions that may be necessary for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when prescribing this medication to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of treatment efficacy and safety in this population.

Pregnancy

The safety of salicylic acid during pregnancy has not been established, and its use is contraindicated due to potential risks to the fetus. There is a risk of teratogenic effects associated with the use of salicylic acid during pregnancy. Therefore, pregnant women should avoid using this product and are advised to consult a healthcare provider for alternative treatments.

Topical salicylic acid should be used with caution during pregnancy, and it is essential for healthcare providers to discuss the potential risks and benefits with patients. Prior to use, consultation with a doctor is recommended to ensure the safety of both the mother and the developing fetus.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication. It is advisable to monitor breastfed infants for any potential effects, although no specific information is available.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. As such, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, given the absence of detailed guidance on its use in this population. Regular monitoring of renal function may be prudent in these cases, although specific recommendations are not provided.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary significantly depending on the substance involved, the amount ingested, and the individual patient's characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and conduct a thorough clinical examination. Supportive care should be initiated as necessary, including airway management, oxygen supplementation, and intravenous fluids.

If specific antidotes or treatments are available for the substance involved, they should be administered according to established protocols. Continuous monitoring of the patient is crucial to identify any changes in clinical status and to guide further management.

In all cases of suspected overdose, it is advisable to contact a poison control center or a medical toxicologist for additional guidance and support in managing the situation effectively.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the understanding of the compound's potential effects in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. It is important to emphasize that if the medication is swallowed, patients should seek medical help or contact a Poison Control Center immediately. This guidance is crucial to ensure the safety and well-being of patients, particularly in households with children.

Storage and Handling

The product is supplied in a configuration that ensures optimal handling and storage. It should be stored at room temperature, away from direct light exposure to maintain its integrity. It is essential to avoid freezing the product, as this may compromise its quality. Additionally, the container must be kept upright to prevent any potential leakage or contamination.

Additional Clinical Information

The medication is administered topically, with a recommended application of a thin layer covering the entire affected area one to three times daily. Clinicians should instruct patients to hold the container 4 to 6 inches from the skin during application. It is advisable to start with one application daily, gradually increasing to two or three times daily as needed or directed by a healthcare provider. If patients experience bothersome dryness or peeling, they should reduce the frequency of application to once a day or every other day.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Clear Acne Body, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)